[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,078
  • Shares Outstanding, K 8,627
  • Annual Sales, $ 1,730 K
  • Annual Income, $ -23,360 K
  • EBIT $ -22 M
  • EBITDA $ -19 M
  • 60-Month Beta 1.12
  • Price/Sales 6.74
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 261.89% (-78.30%)
  • Historical Volatility 109.46%
  • IV Percentile 14%
  • IV Rank 10.54%
  • IV High 1,285.20% on 02/04/26
  • IV Low 141.29% on 05/21/26
  • Expected Move (DTE 9) 0.0425 (3.32%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 35
  • Volume Avg (30-Day) 20
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 4,069
  • Open Int (30-Day) 3,994
  • Expected Range 1.2375 to 1.3225

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.70
  • Number of Estimates 2
  • High Estimate $-0.60
  • Low Estimate $-0.80
  • Prior Year $-1.20
  • Growth Rate Est. (year over year) +41.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1700 +9.40%
on 06/24/26
1.5600 -17.95%
on 06/16/26
-0.1100 (-7.91%)
since 06/08/26
3-Month
1.1700 +9.40%
on 06/24/26
3.6500 -64.93%
on 04/17/26
-2.2180 (-63.41%)
since 04/08/26
52-Week
1.1700 +9.40%
on 06/24/26
16.0000 -92.00%
on 07/28/25
-12.8340 (-90.93%)
since 07/08/25

Most Recent Stories

More News
VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test

HENDERSON, Nev. , July 7, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the release of a new clinical study demonstrating...

VNRX : 1.2800 (-8.57%)
VolitionRx Announces Collaboration with Sysmex

HENDERSON, Nev. , June 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces a collaboration with Sysmex ( TYO: 6869 ...

VNRX : 1.2800 (-8.57%)
VolitionRx Announces Pricing of $4.6 Million Public Offering

$4.6 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the full exercise of warrants

VNRX : 1.2800 (-8.57%)
VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring

Seeks Strategic Partners to Deploy Nu.Q® Platform in Outbreak Zones

VNRX : 1.2800 (-8.57%)
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets

Update Highlights 300% Q1 Revenue Growth, Advance Toward $5 Million Veterinary Milestone, and Active Licensing Discussions with More Than a Dozen Global Diagnostic Leaders

VNRX : 1.2800 (-8.57%)
VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for  Friday, May 15 at 8:30 a.m. U.S. Eastern Time

VNRX : 1.2800 (-8.57%)
VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update

Conference call to take place on Friday, May 15 at 8:30 a.m. U.S Eastern Time

VNRX : 1.2800 (-8.57%)
VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats

The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

VNRX : 1.2800 (-8.57%)
Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing

HENDERSON, Nev. , April 29, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces a major technical milestone with the...

VNRX : 1.2800 (-8.57%)
VolitionRx Announces Acceptance of Compliance Plan by NYSE American

HENDERSON, Nev. , April 23, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that on April 22, 2026,...

VNRX : 1.2800 (-8.57%)

Business Summary

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer...

See More

Key Turning Points

3rd Resistance Point 1.5233
2nd Resistance Point 1.4667
1st Resistance Point 1.4333
Last Price 1.2800
1st Support Level 1.3433
2nd Support Level 1.2867
3rd Support Level 1.2533

See More

52-Week High 16.0000
Fibonacci 61.8% 10.3349
Fibonacci 50% 8.5850
Fibonacci 38.2% 6.8351
Last Price 1.2800
52-Week Low 1.1700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.